Results 141 to 150 of about 86,601 (293)

Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma

, 2011
Barbara‐ann Guinn, Klaus Bosslet, Cindy Lee, Deborah Richardson, Kim Orchard   +4 more
openalex   +2 more sources

A high‐throughput bone marrow 3D co‐culture system to study resistance to BCR signalling targeted agents in B‐NHL

British Journal of Haematology, EarlyView.
Bone marrow (BM) involvement in B‐cell non‐Hodgkin lymphoma (B‐NHL) is associated with poor prognosis, as the BM microenvironment provides a protective niche that promotes therapeutic resistance. We developed a simplified, automated and high‐throughput 3D BM co‐culture model that faithfully reproduces key tumour–stroma interactions.
Alex Zadro, Alberto Arribas, Maria Vittoria Colombo, Eleonora Cannas, Filippo Spriano, Luciano Cascione, Afua Adjeiwaa Mensah, Federico Simonetta, Dalila Petta, Christian Candrian, Chiara Arrigoni, Francesco Bertoni, Matteo Moretti   +12 more
wiley   +1 more source

The Non-Hodgkin's Lymphomas [PDF]

CA: A Cancer Journal for Clinicians, 1985
J E, Ultmann, R H, Jacobs
openaire   +2 more sources

Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma. [PDF]

Cureus
Figueiredo F, Valido T, Chumbo C, Gomes G, Rocha M.   +4 more
europepmc   +1 more source

The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus—related systemic non‐Hodgkin lymphoma [PDF]

, 1999
Giuseppe Rossi, Alessandra Donisi, Salvatore Casari, Alessandro Re, GianPiero Cadeo, Giampiero Carosi   +5 more
openalex   +1 more source

Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL Group

British Journal of Haematology, EarlyView.
A visual overview of the key findings from the 35 papers included in this systematic review evaluating the use of PET volumetric parameters in children, adolescents and young adults with Hodgkin lymphoma. Summary In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification.
S. Claire Gowdy, Jamie E. Flerlage, Jennifer Seelisch, Monica Palese, Tyler Bradshaw, Sharon M. Castellino, Steve Cho, Karin Dieckmann, Bradford S. Hoppe, Scott Howard, Kara M. Kelly, Lars Kurch, Hollie A. Lai, Egesta Lopci, John T. Lucas Jr., Christine Mauz‐Körholz, Kathleen M. McCarten, Neeta Pandit‐Taskar, Heiko Schöder, Jonas Steglich, Dietrich Stoevesandt, Stephan D. Voss, Sarah A. Milgrom   +22 more
wiley   +1 more source

A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree. [PDF]

Cureus
Jain NP, Hirani N, Khilnani AK, Oza C, Patel K.   +4 more
europepmc   +1 more source

Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

, 2010
Michinori Ogura, Toshiki Uchida, Masafumi Taniwaki, Kiyoshi Ando, Takashi Watanabe, Masanobu Kasai, Yosuke Matsumoto, Daisuke Shimizu, Yoshiaki Ogawa, Ken Ohmachi, Hiroki Yokoyama, Kensei Tobinai, the Japanese Bendamustine Lymphoma Study Group   +12 more
openalex   +2 more sources

Medical haematology: Repositioning haematology at the centre of medicine

British Journal of Haematology, EarlyView.
The complementary domains of Medical Haematology and Haemato‐Oncology share a biological framework. The left panel depicts red cells, platelets, coagulation, thrombosis and innate immunity, while the right panel shows lymphoid and myeloid malignancies.
Cheng Hock Toh, Imelda Bates, Sue Pavord
wiley   +1 more source

A Milky Mystery: Chylothorax Unmasking Non-Hodgkin Lymphoma. [PDF]

Cureus
Tangutoori S, Gullapalli D, Kommineni SS, Gudipati MK, Depa J, Gaddam M, Ganti SS.   +6 more
europepmc   +1 more source